Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | EGLN2 | Q96KS0 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29726483 | 1.00 | ALDH1A1 (0.50) | ALDH1A1EGLN2KDM4EGAACA12 | |
| Hydrochloric Acid SCHEMBL29261706 | 0.98 | ALDH1A1 (0.48) | ALDH1A1EGLN2KDM4EGAACA12 | |
| Methane SCHEMBL27670217 | 0.98 | ALDH1A1 (0.48) | ALDH1A1EGLN2KDM4EGAACA12 | |
| Sulfuric Acid SCHEMBL29261683 | 0.89 | CA1 (0.46) | ALDH1A1EGLN2KDM4EGAACA12 | |
| Acetic Acid SCHEMBL29261715 | 0.86 | FFAR1 (0.40) | ALDH1A1EGLN2KDM4EGAAMEN1 | |
| SCHEMBL4047375 | 0.84 | KIF11 (0.59) | ALDH1A1EGLN2CA12CA1CA2 | |
| SCHEMBL29726475 | 0.82 | ALDH1A1 (0.46) | ALDH1A1EGLN2KDM4EGAACA12 | |
| SCHEMBL568906 | 0.82 | ALDH1A1 (0.46) | ALDH1A1EGLN2KDM4EGAACA12 | |
| Sulfuric Acid SCHEMBL29261717 | 0.82 | CA12 (0.40) | ALDH1A1EGLN2CA12CA1CA2 | |
| SCHEMBL229147 | 0.78 | EGLN2 (0.44) | ALDH1A1EGLN2KDM4EGAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117945917-A | Preparation method of 3-fluoro-4-nitrobenzoic acid | 衢州康鹏化学有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117447327-A | Preparation method of 3-fluoro-4-nitrobenzoic acid | 上海万溯药业有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116375549-A | Method and system for synthesizing amide compound from nitrile compound | 深圳湾实验室 | 2023-07-04 | — | — | CN | claimed |
| CN-111668481-B | Preparation method of metal aluminum secondary battery with multi-group organic micromolecules as positive electrode | 北京科技大学 | 2021-12-03 | — | — | CN | claimed |
| CN-109678741-B | Preparation method of 4-amino-3-fluorobenzoic acid | 金凯(辽宁)生命科技股份有限公司 | 2021-11-30 | — | — | CN | claimed |
| CN-111668481-A | Preparation method of metal aluminum secondary battery with multi-group organic micromolecules as positive electrode | 北京科技大学 | 2020-09-15 | — | — | CN | claimed |
| CN-109096783-A | A kind of environment-friendly modified isocyanate resin water-based emulsion and its manufacturing method | 广州木森态新材料科技有限公司 | 2018-12-28 | — | — | CN | claimed |
| EP-2906559-B1 | AZAINDOLINES | HOFFMANN LA ROCHE (CH) | 2017-02-08 | — | — | EP | claimed |
| US-9309248-B2 | Azaindolines | HOFFMANN-LA ROCHE INC. (US) | 2016-04-12 | — | — | US | claimed |
| US-20150266879-A1 | AZAINDOLINES | HOFFMANN-LA ROCHE INC. | 2015-09-24 | — | — | US | claimed |
| EP-2906559-A1 | AZAINDOLINES | F. Hoffmann-La Roche AG (CH) | 2015-08-19 | — | — | EP | claimed |
| WO-2014056871-A1 | AZAINDOLINES | F. HOFFMANN-LA ROCHE AG (CH) | 2014-04-17 | — | — | WO | claimed |
| EP-3887359-B1 | NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING | UNIV COPENHAGEN (DK) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026088070-A1 | COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260090265-A1 | COMPOUND, ORGANIC THIN FILM, PHOTOELECTRIC CONVERSION ELEMENT, IMAGE SENSOR, PHOTOSENSOR AND SOLID-STATE IMAGING APPARATUS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-26 | — | — | US | disclosed |
| US-12534463-B2 | Substituted tricyclic compounds as FGFR inhibitors | INCYTE CORPORATION (US) | 2026-01-27 | — | — | US | disclosed |
| US-4120693-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4111681-A | CYCLOALKANAPYRAZOLE-3-CARBONITRILE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4108628-A | Cycloalkanopyrazole herbicides mixtures | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4059434-A | Cycloalkanapyrazole herbicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266879-A1 | AZAINDOLINES | AZI2, H1-5, CCNY | ALDH1A1 682/4885EGLN2 3233/4885KDM4E 161/4885 |
| US-12534463-B2 | Substituted tricyclic compounds as FGFR inhibitors | FGFR3, FGFR1, FGFR4 | ALDH1A1 2330/4885EGLN2 3871/4885KDM4E 756/4885 |
| US-20260090265-A1 | COMPOUND, ORGANIC THIN FILM, PHOTOELECTRIC CONVERSION ELEMENT, IMAGE SENSOR, PHOTOSENSOR AND SOLID-STATE IMAGING APPARATUS | SLC43A1, CNPY2, SCO2 | ALDH1A1 2453/4885EGLN2 953/4885KDM4E 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.